Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
44 studies found for:    Open Studies | "Hypertriglyceridemia"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hypertriglyceridemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma
Conditions: Hypertriglyceridemia;   Cutaneous T Cell Lymphoma
Intervention: Other: oral glucose tolerance test (OGTT)
2 Recruiting Epanova® for Lowering Very High Triglycerides II (EVOLVE II)
Condition: Hypertriglyceridemia
Interventions: Drug: Epanova;   Drug: Olive Oil
3 Recruiting Hypertriglyceridaemia - Cause and Effects
Condition: Hypertriglyceridaemia
Intervention:
4 Unknown  Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia
Conditions: Hypertension;   Hypertriglyceridemia
Interventions: Dietary Supplement: DHA-EPA;   Drug: Ciprofibrate
5 Not yet recruiting The COMPASS Study: A Study of ISIS-APOCIIIRx in Patients With Hypertriglyceridemia
Condition: Hypertriglyceridemia
Interventions: Drug: ISIS APOCIIIRx;   Drug: Placebo
6 Unknown  Triglyceride Lowering Study
Condition: Hypertriglyceridemia
Intervention: Drug: Omega-3-Acid Ethyl Esters
7 Unknown  Omega-3 Fatty Acid Supplementation in Children
Conditions: Chronic Kidney Disease;   Hypertriglyceridemia
Interventions: Dietary Supplement: n-3 Fatty Acid supplement;   Dietary Supplement: Placebo
8 Unknown  Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides
Condition: Hypertriglyceridemia
Interventions: Drug: 290 mg DCCR;   Drug: 435 mg DCCR;   Drug: 135 mg fenofibric acid;   Drug: Placebo;   Drug: atorvastatin
9 Recruiting Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome;   Diabetes Mellitus, Type 2;   Hypertriglyceridemia
Interventions: Drug: Fenofibrate;   Drug: Simvastatin
10 Recruiting Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Condition: Hypertriglyceridemia
Interventions: Drug: ARI-3037MO;   Drug: Placebo
11 Unknown  Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
Conditions: Insulin Resistance;   Hypertriglyceridemia
Interventions: Drug: Rosiglitazone;   Drug: Fenofibrate;   Behavioral: Weight Loss
12 Not yet recruiting The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL)
Condition: Severe Hypertriglyceridemia
Interventions: Drug: Placebo;   Drug: SC401B 2 capsules;   Drug: SC401B 4 capsules;   Drug: SC401B 6 capsules
13 Recruiting Bioavailability of EPA and DHA From Two Dietary Supplements
Condition: Hypertriglyceridemia
Intervention: Dietary Supplement: DHA-rich fish oil versus Phospholipid-rich fish oil
14 Recruiting PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   Hypertriglyceridemia
Interventions: Drug: Metformin Eicosapentaenoate;   Drug: Metformin HCl and Vascepa
15 Recruiting Fructose Consumption and Metabolic Dysregulation
Conditions: Central Obesity;   Hypertriglyceridemia
Intervention: Dietary Supplement: Fructose
16 Recruiting A Pilot Study to Evaluate the Lipid Effects of TRIA-662
Conditions: Hypertriglyceridemia;   Mixed Hyperlipidemia
Interventions: Drug: TRIA-662;   Drug: Placebo
17 Recruiting Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Conditions: Non Alcoholic Fatty Liver Disease;   Steatohepatitis;   Hypertriglyceridemia;   Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
Interventions: Dietary Supplement: Lovaza;   Other: Omega diet
18 Recruiting Efficacy of LCQ908 on Cardiovascular Risk
Conditions: Coronary Artery Disease;   Hypertriglyceridemia
Interventions: Drug: LCQ908;   Drug: Placebo
19 Unknown  Effects of DPP-4 Inhibition on Triglycerides
Conditions: Type 2 Diabetes;   Hypertriglyceridemia
Intervention: Drug: Saxagliptin
20 Recruiting Lovaza Mechanisms of Action
Condition: Moderate Hypertriglyceridemia.
Intervention: Dietary Supplement: Omega 3 fatty acid (Lovaza)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years